Biologics Market Forecast: USD 612 Billion Valuation by 2030

MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Biologics Market Research Report: Forecast (2025–2030). This report provides a detailed assessment of the Biologics, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.

Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.

Biologics Market Timeline Overview

• Historical Years: 2020–23
• Base Year: 2024
• Forecast Years: 2025–2030

This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.

Download a FREE PDF Sample of the Report: - https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html   (Discover the market potential, platform-specific insights, and key industry trends.)

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Biologics Market Outlook

The Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth. Other factors driving the demand for biologics across the global scale include enhanced usage of monoclonal antibodies for disease treatment, innovation & advancement in the healthcare & biotechnology sectors, and to cure diseases, including anemia, rheumatoid arthritis, osteoporosis, Alzheimer's, etc. Also, diseases like cancer and autoimmune disorders, which pose significant healthcare challenges, underscore the importance of targeted therapeutic interventions, and hence, have been driving the need for biologics over the historical years.

Biologics Market Drivers:

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

View Full Report (All Data, In One Place): - https://www.marknteladvisors.com/research-library/global-biologics-market.html  (Explore in-depth analyses, technological trends, and investment patterns.)

Biologics Market Trends:

Rising Demand for Personalized Medicine Augmenting the Biologics Market Growth – In recent years, there has been a significant increase in the demand for personalized medicines among patients and healthcare professionals across the globe, as they meet the specific needs of an individual. Hence, as biologics can be modified and engineered to fit these requirements, it has been used largely by pharmaceutical companies for the development of personalized medicines, which have been offering more effective & patient-centric treatment options. Thus, the demand for personalized medicine has emerged as a new trend in the Global Biologics Market in recent years.

Biologics Market Segmentation

The study categorizes the Biologics Market into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.

By Therapeutic Application

• Oncology- Market Size & Forecast 2020-2030, (USD Million)
• Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
• Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
• Diabetes- Market Size & Forecast 2020-2030, (USD Million)
• Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
• Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)

By Drug Class

• Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
  • Hormones- Market Size & Forecast 2020-2030, (USD Million)
  • Cytokines- Market Size & Forecast 2020-2030, (USD Million)
• Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
• Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
• Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
• Vaccines- Market Size & Forecast 2020-2030, (USD Million)
• Others- Market Size & Forecast 2020-2030, (USD Million)

By Source

• Microbes- Market Size & Forecast 2020-2030, (USD Million)
• Humans- Market Size & Forecast 2020-2030, (USD Million)
• Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)

Geographical Analysis

The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:

By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific.

Talk to Our Industry Analyst:  - https://www.marknteladvisors.com/query/talk-to-our-consultant/global-biologics-market.html   Get personalized insights into company strategies and regional market dynamics.)

Leading Companies in Biologics Market Worldwide: Players, Analysis & Future Outlook

• Bristol-Myers Squibb
• Pfizer
• Sanofi
• Janssen Biotech, Inc.
• Bayer AG
• Merck & Co.
• Amgen Inc.
• Abbott GmbH
• Novartis
• AstraZeneca Plc
• GlaxoSmithKline Biologicals
• Moderna, Inc.
• Ferring Pharmaceuticals Inc.
• Aimmune Therapeutics, Inc.
• Hoffman La Roche
•  

Key Highlights of the Report

• Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
• Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
• Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
• Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.

Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences

Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/global-biologics-market.html   

Frequently Asked Questions (FAQ)

1. What is the projected growth rate of the Biologics Market?
   2. What are the major factors driving this market’s growth?
   3. Which regions are expected to lead the Biologics Market?
   4. Who are the prominent players in the Biologics Market?
   5. How is the competition structured in this market?
   6. How can I access the full report?

About Us

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Contact Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com